The global severs disease treatment market has been witnessing steady growth over the past few years due to rising incidences of Achilles tendonitis or Severs disease among young athletes and children who are involved in extensive physical activity. Severs disease commonly occurs in physically active children between ages 8 to 12 years and involves inflammation and pain in the growth plate of the heel bone. Non-steroidal anti-inflammatory drugs and heel lifts are considered first line treatment options. Therapy focuses on ice therapy and exercises to strengthen the Achilles tendon. In severe cases, casting or bracing may provide temporary relief. The need for effective treatment of Severs disease has been rising owing to high participation of children and adolescents in sports activities.
The Global Severs Disease Treatment Market is estimated to be valued at US$ 1.34 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the severs disease treatment are AstraZeneca, Horizon Therapeutics plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., LEO Pharma A/S, AbbVie Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Lupin, Dr. Reddy's Laboratories Ltd., IBSA Institut Biochimique SA. Majority of these players are focusing on strengthening their product portfolios by developing advanced and novel formulations.
The rising participation of children and young adults in sports globally is creating lucrative opportunities for players in the Severs Disease Treatment Market Demand. Marketers are emphasizing on expanding awareness regarding prevalence and treatment of severs disease among sports trainers and parents.
Key players are eyeing high growth territories across Asia Pacific and Middle East & Africa for global expansion. These regions have large adolescent population involved in sports and recreational activities. Moreover, improving access to healthcare in developing nations is supporting market growth.
Market Drivers
One of the key drivers for the severs disease treatment market is rising incidence of Achilles tendonitis or severs disease owing to increasing participation in sports and physical activities among children and adolescents across the world. As per recent studies, over 30% of young athletes reported experiencing symptoms of severs disease at some point.
Market Restrains
High costs of advanced formulations coupled with lack of awareness regarding severs disease in rural and underdeveloped regions are some of the major challenges restraining swift market growth. Moreover, non-compliance to treatment and premature discontinuation also hampers complete recovery from the condition.
Segment Analysis
The sever's disease treatment market is dominated by over-the-counter medication sub segment. Over-the-counter medications are easily available at affordable prices to treat heel pain caused by sever's disease. These medications provide quick relief to patients and do not require a prescription. Oral medications are the next major sub segment for treat sever's disease. Oral medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) are prescribed to patients to relieve pain and inflammation. Physical therapy is also gaining prominence for treating sever's disease in children. It focuses on stretching and strengthening the Achilles tendon and calf muscles to provide long term relief.
Global Analysis
The North America region dominates Severs Disease Treatment Market Regional Analysis owing to high awareness about this pediatric foot condition and availability of advanced treatment options. Europe is the second largest regional market supported by rising healthcare spending. However, Asia Pacific region is expected to witness the highest growth during the forecast period due to increasing patient pool in developing countries like India and China. Government efforts to improve healthcare infrastructure and rising per capita incomes will boost sales of sever's disease treatment products in Asia Pacific region.
Get More Insights on- Sever's disease Treatment market
For Deeper Insights, Find the Report in the Language that You want:
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
